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ABSTRACT
Homing endonucleases are enzymes that catalyze
DNA sequence specific double-strand breaks and
can significantly stimulate homologous recombina-
tionatthesebreaks.Theseenzymeshavegreatpoten-
tial for applications such as gene correction in gene
therapy or gene alteration in systems biology and
metabolic engineering. However, homing endonuc-
leases have a limited natural repertoire of target
sequences,whichseverelyhampertheirapplications.
Here we report the development of a highly sensitive
selectionmethodforthedirectedevolutionofhoming
endonucleasesthatcouplesenzymaticDNAcleavage
with thesurvivalof host cells.UsingI-SceI asamodel
homing endonuclease, we have demonstrated that
cells with wild-type I-SceI showed a high cell survival
rate of 80–100% in the presence of the original I-SceI
recognition site, whereas cells without I-SceI showed
a survival rate ,0.003%. This system should also be
readily applicable for directed evolution of other DNA
cleavage enzymes.
INTRODUCTION
Homing endonuclease are highly speciﬁc DNA endonul-
ceases, encoded within mobile introns or inteins (1). They
recognize speciﬁc 14–40 bp DNA sequences and catalyze
site-speciﬁc double-strand breaks (DSBs) in the chromosome.
Homing endonucleases have great potential to be applied in
gene targeting, as the site-speciﬁc DNA DSBs that they intro-
duce can signiﬁcantly stimulate homologous recombination
(2). Gene correction at the mutated locus by means of homo-
logous recombination has clear advantages over gene addition
by virus-driven random integration, which suffers from the
consequences of transgene silencing and improper activity.
Although homologous recombination is a more attractive
method, it is presently unfeasible in most cases owing to
the generally low frequency of homologous recombination.
Many attempts have been made to increase the efﬁciency
of homologous recombination in mammalian cells, such as
increasing the size of the region of homology with the target
locus, using isogenic genomic DNA, or improving the selec-
tion procedures (3). As a DNA DSB is lethal to cell survival, it
triggers the cell repair machinery and greatly increases the
frequency of homologous recombination at this site. Introduc-
tion of a DNA DSB by homing endonuclease in the gene to be
replaced results in much enhanced homologous replacement
by the incoming DNA, even with relatively low stretches of
homologous DNA sequence (3,4).
However, the limited natural repertoire of target sequences
of homing endonucleases severely hampers their application,
and the lack of an efﬁcient selection method restricts the
use of powerful directed evolution approaches for engineering
of homing endonucleases with altered sequence speciﬁcity
in vitro (5). Seligman et al. (6) developed a positive and
negative screening method for assaying homing endonuclease
activity. In this system, the cleavage of the target DNA seq-
uence by homing endonuclease results in the host cell being
converted from Kan
+ to Kan
  or from LacZ
+ to LacZ
 .
Sussman et al. (7) successfully used this screening system
to verify the target DNA speciﬁcity of homing endonuclease
I-CreI variants. However, the throughput of such a system is
rather limited owing to its screening nature. The in vivo selec-
tion system for homing endonuclease activity developed by
Gruen et al. (8) links the catalytic activity of a homing endo-
nuclease to the survival of an Escherichia coli cell through a
DNA cleavage event. This system comprises two plasmids:
one plasmid encodes a mutant barnase gene with two amber
(TAG) stop codons under an inducible arabinose promoter,
followed by tandem endonuclease cleavage sites; and the other
plasmid contains a fusion protein of homing endonuclease and
Amber suppressor tRNA supE under the constitutive lac pro-
moter. The coexpression of the mutant barnase gene and the
tRNA expression cassette fusion protein results in cell death.
However, the cleavage of the target DNA sequence by the
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expression by arabinose can eliminate the plasmid encoding
mutant barnase and lead to cell survival. This system can be
applied to assay homing endonuclease activity in vivo and has
higher sensitivity than the traditional in vitro assay. However,
the drawbacks of this system include a relatively high back-
ground survival (survival of cells harboring both plasmids in
the presence of arabinose, but lacking homing endonuclease
activity) and a low sensitivity (cells with the wild-type homing
endonuclease I-SceI showed a low cell survival rate of 25% in
the presence of two tandem copies of the original I-SceI recog-
nition site), which impedes its application in directed evolu-
tion of homing endonucleases with altered target sequence.
We have developed an in vivo endonuclease activity assay
utilizing two different plasmids that share the same principle
of Gruen’s system. In our system, cells with wild-type I-SceI
show a high cell survival rate of 80–100% in the presence of
one copy of the original I-SceI recognition site, and by incorp-
oratingamutantLacY(A177C) asanarabinosetransporter,the
survival rate of cells without I-SceI is <0.003%. Such a high
signal-to-background ratio makes this system suitable for
application in directed evolution.
MATERIALS AND METHODS
Plasmid construction
To construct plasmid pBAD-ccdB, the ccdB gene was amp-
liﬁed from pTCKJ02 (9) (a gift from J. D. Keasling) with
primer NheI-ccdB, catgca gctagc GGAGTG aaacgatgcagttt
aaggtttacacctataaaaga (NheI site shown in italic), and ccdB-
R(X+S), agtacg gcatgc cgtatg tctaga ttatattccccaaaacatcaggt-
taat (XbaI and SphI sites shown in italic), and cloned into the
NheI and SphI sites of pBAD18 (10) (a gift from J. M. Slauch).
Primer NheI-ccdB also contains the Shine-Dalgarno (S.D.)
sequence from pBAD18s (10), shown in capital letters. For
ribosome binding site (RBS) engineering, this S.D. sequence
was replaced by NNNNNN to form the random library and the
best mutant identiﬁed from this library was named p11-ccdB.
Therecognition sequenceofI-SceIwas inserted intop11-ccdB
at XbaI and SphI sites by oligos 50-ctagc attacgc TAGG-
GATAACAGGGTAAT atcacgc tctaga catacg gcatg-30 and
50-c cgtatg tctaga gcgtgat ATTACCCTGTTATCCCTA
gcgtaatg-30 (recognition sequence of I-SceI shown in capital
letters and XbaI and SphI sites shown in italic) to form p11-
ccdB-wtx1. A modiﬁed I-SceI recognition sequence was
similarly inserted into p11-ccdB by oligos 50-ctagc attacgc
TAGGGATAACAAGGTAAT atcacgc tctaga catacg gcatg-
30 and 50-c cgtatg tctaga gcgtgat ATTACCTTGTTATCCCTA
gcgtaatg-30 (modiﬁed recognition sequence of I-SceI shown in
capital letters and XbaI and SphI sites shown in italic) to form
p11-mISceI. Ligation of these oligos into p11-ccdB XbaI and
SphI sites abolished the original XbaI site and introduced
a new XbaI site (shown in italic). Additional recognition
sequence can be inserted into the new XbaI and SphI sites.
A synthetic cassette 50-tacgtacga tttaaa taggcct-30 was
ligated into the large NdeI–ClaI fragment of p11-ccdB-wtx1
in order to introduce a StuI site. Mutant LacY(A177C)
under the lac promoter was ampliﬁed from pLacYA177C
(11) (a gift from J. E. Cronan) with primers plac-StuI, gagctc
aggcct gactcactatagggagaccg, and LacY-StuI-R, ctagct aggcct
taagcgacttcattcacct (StuI sites shown in italic), and inserted
into the StuI site of p11-ccdB-wtx1 to form p11-LacY-wtx1.
Plasmid pTrc99a was used as a template for I-SceI cloning.
First, the ampicillin resistance gene in pTrc99a was replaced
by kanamycin resistance gene to form pTrc-KM. The large
fragment of pTrc99a digested with BspHI was treated with T4
DNA polymerase (New England Biolabs, Beverly, MA) to
form blunt ends, and it was ligated with the blunt ended
small fragment of pET26b digested with AlwNI and XhoI.
Second, the pBR322 origin of replication in pTrc-KM was
replacedby p15aorigintoformpTrc-p15a. Thelargefragment
of pTrc-KM from AlwNI and HpaI digestion was treated with
T4 DNA polymerase to form blunt ends, and ligated with
the StuI digested PCR product of pACYCDuet-1 (Novagen,
Madison, WI) ampliﬁed with primers StuI-D1, tattaaaggcct
gctccagtggcttctgtttc, and StuI-D2, ataatt aggcct cttga-
gagccttcaacccag (StuI sites shown in italic). Homing endonuc-
lease I-SceI was ampliﬁed from pSCM525 (12) (a gift from
B. Dujon) with primers EcoRI–SceI0, atcagt gaattc aggaaactc-
gagatgaaaaatattaaaaaaaa (EcoRI site shown in italic), and
KpnI-Isce-2-C, atgccg ggtacc ttattttaaaaaagtttcgg (KpnI site
shown in italic), and cloned into the KpnI and EcoRI sites of
pTrc-p15a to form pTrc-ISceI. pTrc-D44A, containing a mut-
ant I-SceI (D44A) was constructed using megaprimer PCR
technique (13). A ﬁrst PCR was performed with D44A0-C,
gatgtaagcagcacccaggat, and EcoRI–SceI0 using pSCM525 as
template to form a megaprimer. This megaprimer, in combina-
tion with KpnI-Isce-2-C, was used to amplify pSCM525 to
obtain mutant I-SceI (D44A), which was then cloned into
pTrc-p15a.
Ribosome binding site strength engineering
The ccdB gene was ampliﬁed from pTCKJ02with primers rbs-
ccdB-F, ttttgg gctagc nnnnnn aaacgatgcagtttaaggtttacacctataa
(NheI site shown in italic), and ccdB-R(X+S), and cloned into
pBAD-ccdB digested with NheI and SphI. The  6t o 12
bases of the ccdB gene were randomized with degenerate
primers to form the random library of S.D. sequences. This
library was transformed into BW25141 (lacI
q rrnBT14
DlacZWJ16DphoBR580hsdR514DaraBADAH33DrhaBADLD78
galU95 endABT333 uidA(DMluI)::pir
+ recA1) (14,15) (a gift
from W. W. Metcalf) and plated on Luria–Bertani (LB) plates
in the presence of 100 mg/ml ampicillin. Colonies formed on
the plates were transferred with sterile toothpicks into round-
bottom96-wellplates (EvergreenScientiﬁc,LosAngeles,CA)
containing 50 ml LB plus 100 mg/ml ampicillin and grown
overnight at 37 C with vigorous shaking. This overnight cul-
ture was then diluted with 200 ml per well sterile double-
distilled water and 5 ml of this culture was transferred to the
corresponding wells of two sterile ﬂat-bottom 96-well plates
(Rainin Instrument, Oakland, CA) containing 200 mlo fL B
plus 100 mg/ml ampicillin with or without 10 mM arabinose
and incubated at 37 C for 16 h, after which OD600 readings
were taken by using a Spectramax 340PC plate reader
(Molecular Devices, Sunnyvale, CA). Owing to the toxic
nature of CcdB, it was reasoned that strong RBS would
lead to little or no cell growth in the absence of arabinose
induction, while weak RBS would allow high cell survival
rates even at the maximum arabinose concentration. A total
of 800 colonies were picked and 13 clones showing healthy
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presence of 10 mM arabinose were selected. These clones
were then plated on LB plates containing 100 mg/ml ampicillin
and 0,1, 4or10 mM arabinose,and incubatedat37 Cfor24 h.
Clone p11-ccdB, which showed normal colony growth on the
plate with 0 mM arabinose and no colony on plates with 4 mM
arabinose, was chosen for future experiments. DNA sequen-
cing of this clone revealed its S.D. sequence as GATTGA.
In vivo activity assay
The selection strain was made by transforming E.coli
BW25141 with the appropriate reporter plasmid and plating
on a LB plus 100 mg/ml ampicillin plate. A single colony from
the transformation plate was picked and grown in 500 ml of
LB plus 100 mg/ml ampicillin and electrocompetent cells of
the selection strains were prepared following standard proto-
cols (16). It is important that cells do not grow to log phase at
any stage during competent cell creation. Typically, 50 mlo f
the competent selection strains were transformed with 1–
100 ng of pTrc-ISceI/D44A or pTrc-p15a plasmids and the
cultures were immediately recovered in SOC media and sha-
ken at 37 C for 5 min. The culture was then diluted 5-fold with
SOC media pre-warmed at 37 C media. For selection strains
not containing the lacY(A177C) gene, the culture was induced
with 0.1 mM isopropyl-b-D-thiogalactopyranoside (IPTG)
(Sigma, St Louis, MO) and shaken at 37 C for 40 min before
plating on agar plates. For the selection strain containing p11-
LacY-wtx1, a ﬁnal concentration of 0.5 mM IPTG was used to
induceproteinexpressionfromtheTrcandlacpromoters.This
culture was allowed to grow at 37 C for 70 min followed by 1
h incubation at 30 C prior to plating on agar plates. An aliquot
ofcellswasspreadonplatesofLBplus50mg/mlkanamycinto
estimate the total number of transformants. A second aliquot
was plated on LB plus 50 mg/ml kanamycin plus 10 mM
arabinose plates. All plates were incubated at 37 C for 12–
24 h until colonies were clearly visible and colonies were
counted manually to estimate the survival rate. The survival
rate was calculated by dividing the number of colonies formed
on the arabinose-containing plate bythe number ofcolonies on
the kanamycin only plate, after accounting for dilution factors.
RESULTS
Designandconstructionofaselectionsystemforhoming
endonuclease activity
Our selection system involves two plasmids, which link a
DNA cleavage event with E.coli cell survival. The reporter
plasmid, p11-ccdB-wtx1 (Figure 1), encodes the toxin gene
ccdBundertheinducibleBAD promoter, followed byonecopy
of the endonuclease cleavage site. The ccdB gene was iden-
tiﬁed in F-plasmid (17) and encodes a small protein with 101
amino acids. CcdB poisons DNA gyrase and is responsible for
the killing of F-plasmid free segregants during cell division
(17,18). A second plasmid, pTrc-ISceI (Figure 1), contains
homing endonuclease I-SceI under the Trc promoter. I-SceI
expression is inducible by IPTG. The cleavage of reporter
plasmid by I-SceI linearizes the reporter plasmid and causes
it to be quickly degraded inside an E.coli cell by RecA (19).
Thus, the expression of ccdB is eliminated before induction by
arabinose, resulting in cell survival.
One of the key criteria of this system is the tight regulation
of ccdB gene expression so that it only exerts its toxic
effect upon arabinose induction. We chose the BAD pro-
moter because of its high induction ratio and tight regulation
by arabinose (10). The ccdB gene was initially cloned into
pBAD18 with a RBS—GGAGTG—borrowed from pBAD18s
(10) to form pBAD-ccdB. pBAD18 plasmid has the pBR322
origin of replication and maintains 100–300 copies per cell.
Transformation of pBAD-ccdB into E.coli BW25141 resulted
in much slower cell growth in LB media containing 100 mg/ml
ampicillin and low cell survival rate on the agar plate, indic-
ating thatthe low level ofccdB expression even underthe BAD
promoter is still toxic to E.coli cells. To further decrease the
intracellular CcdB protein concentration, we decided to
decrease the level of ccdB translation by modifying its
RBS. Using the RBS strength engineering method described
in Materials and Methods section, mutant p11-ccdB, which
displayed normal cell growth on LB plus 100 mg/ml ampicillin
plate and no cell growth on LB plus 100 mg/ml ampicillin plus
Figure 1. The two plasmids used in our in vivo selection system. The reporter
plasmidp11-LacY-wtx1encodesthetoxinCcdBgeneundertheinducibleBAD
promoter and a single copy of the endonuclease cleavage site which is readily
extendable to multiple copies. It also encodes an arabinose transporter gene
lacY(A177C) under the lac promoter to facilitate the induction of ccdB by
arabinose. Plasmid map of p11-ccdB-wtx1 is similar to that of p11-LacY-
wtx1, except that it lacks the lac promoter and lacY(A177C) gene. Plasmid
pTrc-ISceI contains homing endonuclease I-SceI under the Trc promoter.
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this clone revealed its S.D. sequence to be GATTGA. One
copy of the original I-SceI recognition sequence was then
inserted after ccdB in p11-ccdB to form the reporter plasmid
p11-ccdB-wtx1 (Figure 1).
The second plasmid, pTrc-ISceI encodes homing endonuc-
lease I-SceI under the inducible Trc promoter. It has a p15a
origin of replication and is maintained inside an E.coli cell
with  15 copies. I-SceI was the ﬁrst discovered homing endo-
nuclease (20,21) and it belongs to the LAGLIDADG family. It
recognizes an asymmetric DNA sequence of 18 bp 50-TAGG-
GATAA#CAGGGTAAT-30 and cleaves its target in the
presence of Mg
2+ to generate a 4 nt 30 overhang (22). We
used I-SceI to demonstrate the linkage between DNA cleavage
and cell survival. The selection strain harboring the reporter
plasmid (p11-ccdB-wtx1) was transformed with either the
plasmid containing homing endonuclease (pTrc-ISceI) or con-
trol plasmid (pTrc-p15a) and subjected to the in vivo activity
assay. All results are summarized in Table 1. Transformation
with pTrc-ISceI resulted in a survival rate of 80–100%,
whereas transformation with pTrc-p15a plasmid resulted in
a survival rate of only 0.3–0.9%. As an additional control,
the active site residue Asp44 was mutated to Ala to generate
an inactive I-SceI variant D44A (23). pTrc-D44A has a sur-
vival rate of 0.5–0.9%, similar to that of pTrc-p15a. We also
modiﬁed the recognition site of I-SceI to 50-TAG GGA TAA
GAa GGT AAT-30 (p11-mISceI, a is the single base mutation),
which should not be cleaved by I-SceI (22). Transformation of
the selection strain containing this mutant recognition site
(p11-mISceI) with pTrc-ISceI resulted in a survival rate of
<0.02%. These results indicate that our in vivo selection assay
can efﬁciently link the DNA cleavage event to the cell survival
through the activity of I-SceI and DNA sequence speciﬁcity.
Of note, based on previous studies (8), we thought the
sensitivity of this in vivo selection assay may be further
improved by increasing the concentration of substrate DNA
sites. However, introduction of two tandem copies of I-SceI
recognition site to the reporter plasmid did not yield signiﬁc-
antly higher survival rate (data not shown), which may be
owing to the very high survival rate of cells harboring only
one copy of the I-SceI recognition site (80–100%) in our
system.
Optimization of a selection system for homing
endonuclease activity
Transformation of the selection strain harboring p11-ccdB-
wtx1 with control plasmid (pTrc-p15a) resulted in a 0.3 to
0.9% cell survival rate, and longer recovery time at 37 C
shaker after electroporation resulted in even higher back-
ground survival rate. Although such background survival
can be greatly reduced by shortening the posttransformation
recovery time in liquid SOC at37 C,transformationefﬁciency
and the survival rate of the selection strain transformed with
pTrc-ISceI also decreases. This background survival is prob-
ably owing to the partial or complete loss of the reporter
plasmid in the absence of antibiotic selection pressure (ampi-
cillin) during recovery in liquid SOC media and on selection
plates containing only kanamycin and arabinose.
The BAD promoter is known to be subject to all-or-none
induction, because genes encoding the arabinose transporters
(araE and araFGH) are also under the regulation of the BAD
promoter (24). This autocatalytic mechanism causes only a
fraction of the cells in the population to be fully induced while
the remainingcells stay uninduced for an extended time period
(25). We suspect this mechanism may also delay the overall
induction from the BAD promoter. To overcome this problem,
we introduced a mutant lacY (A177C) gene as an additional
arabinose transporter (11). The lacY(A177C) gene was placed
under the lac promoter on the reporter plasmid to form p11-
LacY-wtx1 (Figure 1). Selection strainsharboring this plasmid
were transformed with pTrc-p15a or pTrc-ISceI and subject to
an in vivo activity assay. The survival rate of pTrc-p15a cells
was <0.003% (Table 1), 100- to 300-fold lower than that of the
Figure 2. E.coli BW25141 was transformed with p11-ccdB-wtx1 and equal
amount of cells were plated on agar plates containing 100 mg/ml ampicillin
and 0, 1, 4 or 10 mM arabinose. These cells can form healthy colonies on
ampicillin plates but lack the ability to form colonies on 4 mM arabinose-
containing plates, suggesting that our engineered S.D. sequence successfully
decreasesthe basalccdBexpressionlevelbutdoesnotimpairtheinducedccdB
expression level.
Table 1. Summary of the in vivo activity
Selection strains
a Survival rate
b
pTrc-IsceI pTrc-p15a pTrc-D44A
p11-wtx1 80–100% 0.3–0.9 0.5–0.9%
p11-LacY-wtx1 80–100% <0.003% ND
c
p11-mISceI <0.02% ND ND
aSelection strains were obtained by transforming BW25141 with plasmid p11-
wtx1, p11-LacY-wtx1, and p11-mISceI and made electrocompetent.
bThe appropriate selection strains were transformed with plasmids pTrc-ISceI,
pTrc-p15a and pTrc-D44A, and aliquots were plated on LB plus 50 mg/ml
kanamycin with or without 10 mM arabinose. The survival rate was calculated
bydividingthenumberofcoloniesformedonthearabinose-containingplateby
thenumberofcoloniesonthekanamycinonlyplate,afteraccountingfordilution
factors.
cND, not determined.
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survival rate of 80–100% (Table 1) was obtained from the
transformation with pTrc-ISceI.
To evaluate the efﬁciency of this system for identifying
active homing endonuclease variants, selection strain harbor-
ing p11-LacY-wtx1 was transformed with a plasmid mixture
containing a 1:10
4 molar ratio of pTrc-ISceI : pTrc-D44A and
subject to the in vivo activity assay. A total of 1.2 · 10
6 clones
were screened and 60 colonies were observed on LB plus
50 mg/ml kanamycin plus 10 mM arabinose plates. Four ran-
dom clones were picked and DNA sequenced, and two of the
selected clones contained pTrc-ISceI, suggesting a 5000-fold
enrichment. All colonies formed on the selection plates were
pooled together and grown in LB plus 50 mg/ml kanamycin
media overnight. Their plasmids were isolated, re-transformed
into the same selection strain and subjected to in vivo activity
assay, and an aliquot was plated on LB plus 50 mg/ml kana-
mycin plus 10 mM arabinose. Four random clones from the
selection plate were subjected to DNA sequencing, and as
expected, all four clones contained pTrc-ISceI. This assay
suggests that the extremely rare functional clones from the
library can be readily identiﬁed using our in vivo selection
system,and thus we consider this new system to be suitable for
directed evolution experiments.
DISCUSSION
In this work we have developed a highly sensitive in vivo
selection method suitable for directed evolution of homing
endonucleases with altered sequence speciﬁcity. This method
involves the coexpression of a toxin, CcdB, and a homing
endonuclease of interest, I-SceI, and couples cleavage of
the plasmid expressing CcdB by I-SceI with cell survival.
The simultaneous expression of the LacY(A177C) transporter
protein ensures a low background survival of toxin-containing
cells, thereby ensuring minimal likelihood of false positives
during library screening. Our system has a number of advant-
ages over the existing in vivo selection system developed by
Gruen et al. (8).
(i) Simplicity: the mechanism of our system is more straight-
forward than Gruen’s system but has the same or greater
effectiveness. In Gruen’s system, the elimination of
unwanted clones requires the expression of two different
proteins—mutant barnase and Amber suppressor tRNA
supE—to kill cells. In our system, only one protein—
CcdB—is required to give rise to the toxic phenotype.
Furthermore, in Gruen’s system, it is necessary to express
the target homing endonuclease as an N-terminal fusion
protein of Amber suppressor tRNA supE. Such fusion
may introduce unexpected and unwanted homing
endonuclease—suppressor supE interactions. Our system
does not have such complications.
(ii) Sensitivity: our system is much more responsive to the
homing endonuclease cleavage event. The survival rate
of cells with wild-type I-SceI and one copy of the original
I-SceI recognition site is 80–100% in our system, whereas
in Gruen’s system, the survival rate of cells harboring I-
SceI and two copies of the I-SceI recognition site is 25%.
Considering that the survival rate of the selection system
can not be >100% and it was proportional to the concen-
trationofsubstrateDNAsites(8),oursystemismuchmore
sensitive than that developed by Gruen et al. (8). The high
cell survival rate obtained in our system is probably owing
to the higher I-SceI expression level resulting from using
the Trc promoter instead of the lac promoter, and longer
posttransformation recovery time at 37 C (40 or 70 min in
oursystemversus20mininGruen’ssystem)beforeplating
on arabinose-containing plates. By introducing an arabi-
nose transporter gene lacY(A177C), the background cell
survival rate is kept under 0.003%, which makes this sys-
tem feasible for directed evolution approaches.
Introduction of mutant lacY(A177C) is critical for the low
background survival rate. The background survival of cells
without I-SceI is probably owing to the complete or partial
loss of reporter plasmid that causes the reduction or elimina-
tion of the toxin ccdB gene expression. This gradual loss of
reporter plasmid should be proportional to the number of cell
divisions, or the time of cell growth in media lacking the
appropriate antibiotic selection pressure. After transformation,
the selection strains were recovered ﬁrst in liquid SOC media
and then plated on arabinose-containing agar plates; in both
stages no ampicillin was added to maintain the reporter plas-
mid. In most cases only a subpopulation of cells are imme-
diately induced upon plating on arabinose-containing plate
while the rest of the cells undergo arabinose induction
much later. This is due to the autocatalytic transcription mech-
anism of the BAD promoter where a threshold of intracellular
transporter concentration is required to accumulate enough
inducer at the time the sugar is added. This initial accumula-
tion results in the induction of increased expression of trans-
porters that catalyze the uptake of more sugar, leading to
further induction (25,26). This extra time required for the
full induction of BAD promoter might be sufﬁcient for the
slow-inducing cells to lose their reporter plasmid. Thus, we
introduced a recombinant arabinose transporter gene,
lacY(A177C) (11), to (i) facilitate the homogeneous induction
of ccdB by arabinose within the cell population, (ii) force the
immediate induction by arabinose upon plating on the
arabinose-containing plates, and (iii) raise the intracellular
arabinose concentration and in turn increase the transcription
efﬁciency of each individual BAD promoter so that cells with
decreased reporter plasmid copy number can still produce
enough CcdB to kill the cell. A modiﬁed in vivo activity
assay, with extended posttransformation recovery time at
37 C and an additional incubation at 30 C, was necessary
for the selection strain containing p11-LacY-wtx1 to have a
high (80–100%) survival rate with pTrc-ISceI. This modiﬁed
in vivo activity assay does not have signiﬁcant effect on the
background cell survival rate.
The success of our system heavily relies on the tight regu-
lation of toxin ccdB expression. The BAD promoter has rapid
kinetics (27), a high induction ratio of up to 1200-fold (10) and
tight control (28), and was thus chosen as the promoter for
ccdB. However our initial effort of expressing ccdB from an
existing BAD promoter still suffered relatively high basal level
of ccdB expression that resulted in a low survival rate in the
absence of arabinose. Thus, further engineering was necessary
to decrease this basal level expression while maintaining
the relative high expression level upon induction. We ﬁrst
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moter is catabolite sensitive (29). However cells lacking this
essential cyaA gene show severely retarded growth, as was
observed in other studies (14). Subsequent efforts focused on
methods such as modifying mRNA stability via RNA hairpins
(9) and verifying plasmid copy number (30). We decided the
simplest way to achieve our goal was to modify the S.D.
sequence. This method has been applied previously to obtain
a higher protein expression level (31), but has never been used
for the purpose of decreasing the target protein expression
level. As shown in our study, RBS engineering is indeed an
extremely simple and effective way to modify protein expres-
sion levels, as we observed a wide range of protein expression
levels from our library screening. This strategy may be useful
for the over-expression and puriﬁcation of toxic proteins when
a low basal expression level is necessary to maintain cell
survival in the uninduced state. It may also ﬁnd applications
in metabolicengineering whenseveralgenes are required tobe
expressed simultaneously inside an E.coli cell to different
degrees. By assigning a different S.D. sequence to each indi-
vidual target gene, these genes can be differentially expressed
from a common promoter. In fact, this mechanism has been
widely used by nature when an operon is regulated by a single
promoter and the members of the operon are expressed at
various levels according to their own S.D. sequence.
The survival rate of pTrc-ISceI in the selection strain
containing a modiﬁed I-SceI recognition site (p11-mISceI)
(<0.02%) is much lower than that of pTrc-p15a in the strain
containing the original I-SceI recognition site (p11-ccdB-
wtx1) (0.3–0.9%). As discussed previously, the background
cell survival is probably owing to the partial or complete loss
of the reporter plasmid, which should correlate with the num-
ber of cell divisions. Cell division can be inﬂuenced by many
factors, suchasthe metabolic burden encountered byeach cell.
We reason that the lower survival rate of pTrc-ISceI may be
owing to the induced expression of I-SceI, which consumes
cellular energy and slows the cell cycle of division. In the case
of pTrc-p15a, more cellular resources can be used for cell
growth and division.
As a test run, wild-type I-SceI and mutant D44A were
mixed at a molar ratio of 1:10
4 and transformed into selection
strain containing p11-LacY-wtx1. It was demonstrated that the
0.01% wild-type I-SceI in the library can be readily identiﬁed
using our in vivo activity assay.
In principle, this system can also be modiﬁed to include a
negative selection to select for homing endonuclease mutants
that display a speciﬁcity shift. This can be readily achieved by
incorporating the original recognition sequence to the homing
endonuclease encoding plasmid (pTrc-ISceI). Transformation
of the reporter strain with variants that retain signiﬁcant cleav-
age activity toward the original sequence results in the loss
of these variants encoding plasmids. As a result, only variants
with a shifted speciﬁcity will be selected from the library of
variants created by directed evolution approaches.
We are currently applying this method for the engineering
of I-SceI variants with altered sequence speciﬁcity. So far,
we have screened a library of 2 · 10
6 I-SceI variants using
this system and we have successfully identiﬁed a few
variants that showed signiﬁcant activity towards the new
DNA substrate (TAGGGATAACAGGGCCTA) (data not
shown). In principle, this in vivo selection system may be
used to assay the activity and perform directed evolution of
other DNA cleavage enzymes.
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